Skip to main content

Month: July 2020

X4 Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on July 30, 2020

CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it will report its financial results for the second quarter ended June 30, 2020, and provide an update on recent business highlights, on July 30, 2020.The Company will host a conference call and webcast on the same day at 8:30 a.m. ET to discuss these financial results and business highlights. The conference call can be accessed by dialing (866) 721-7655 from the United States or (409) 216-0009 internationally, followed by the conference ID: 6091009. The live webcast can be accessed on the investor relations section of X4 Pharmaceuticals’ website at www.x4pharma.com. Following the completion...

Continue reading

Genocea to Host Second Quarter 2020 Corporate Update Conference Call & Webcast

CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its second quarter 2020 financial results and corporate update conference call and live audio webcast on Thursday, July 23rd at 8:30 a.m. EDT.Interested participants may access the conference call by dialing (844) 826-0619 (domestic) or (315) 625-6883 (international) and referring to conference ID number 8894505. To join the live webcast, please visit the presentation page of the investor relations section of the Genocea website at https://ir.genocea.com/events-and-presentations. A webcast replay will be available on the Genocea website beginning approximately two hours after the event and will be archived for 90 days.About Genocea Biosciences, Inc.Genocea’s...

Continue reading

Vera Bradley and Warner Bros. Consumer Products Unveil Harry Potter™ + Vera Bradley Collection

FORT WAYNE, Ind., July 16, 2020 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (NASDAQ: VRA), a leading American bag and luggage company and iconic lifestyle brand, and Warner Bros. Consumer Products, are excited to introduce a Harry Potter™-inspired capsule collection including backpacks, handbags, travel duffels, accessories, cozy favorites, and more.The captivating collection features an exclusive Home to Hogwarts™ pattern with nods to the iconic symbols from the Harry Potter™ film series and Vera Bradley’s signature bright, colorful touch. Select pieces are also available in patterns named and styled after each Hogwarts™ house — so whether you aspire to the bravery of Gryffindor, the ambition of Slytherin, the wisdom of Ravenclaw, or the loyalty of Hufflepuff, there’s something for everyone. In true Vera Bradley fashion, the smart styles...

Continue reading

HCI Group Sets Second Quarter 2020 Earnings Call for Thursday, August 6, 2020 at 4:45 p.m. ET

TAMPA, Fla., July 16, 2020 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, will hold a conference call on Thursday, August 6, 2020, at 4:45 p.m. Eastern time to discuss results for the second quarter ended June 30, 2020. Financial results will be issued in a press release after the close of the market on the same day.HCI management will host the presentation, followed by a question and answer period.Interested parties can listen to the live presentation by dialing the listen-only number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.hcigroup.com.Date: Thursday, August 6, 2020Time: 4:45 p.m. Eastern time (1:45 p.m. Pacific time)Listen-only toll-free number: (844) 369-8774Listen-only...

Continue reading

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide in Bardet-Biedl Syndrome in Diabetes, Obesity and Metabolism

— Study demonstrated that treatment with setmelanotide reduced body weight and hunger in individuals living with Bardet-Biedl syndrome —BOSTON, July 16, 2020 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, announced today that results from its Phase 2 study evaluating setmelanotide for the treatment of obesity and insatiable hunger, known as hyperphagia, in patients living with Bardet-Biedl Syndrome (BBS) were published in the peer-reviewed journal Diabetes, Obesity and Metabolism. As previously reported, data from the study demonstrate that treatment with setmelanotide, the company’s melanocortin-4 receptor (MC4R) agonist, reduced body weight and hunger in individuals...

Continue reading

Norovirus Gastroenteritis Costs an Estimated $10.6 Billion Each Year in the United States

SOUTH SAN FRANCISCO, Calif., July 16, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, and has a Phase 2 ready norovirus vaccine program, today announced that a new study was published in the Journal of Infectious Diseases today, which concluded that norovirus gastroenteritis costs the United States an estimated median of $10.6 billion each year. In particular, norovirus outbreaks that are widely publicized are only the tip of the iceberg and constitute less than 10% of all the costs. The vast majority of the costs come from sporadic cases in the community.These results came from a computational model that simulated the course of a norovirus infection and quantified its clinical and economic...

Continue reading

Provectus Biopharmaceuticals Announces Change to Board of Directors

KNOXVILLE, TN, July 16, 2020 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today is pleased to announce the addition of Webster Bailey to the Company’s Board of Directors (the “Board”), effective as of July 20, 2020. Mr. Bailey is a member of the board of directors of the Clover Fork Coal Company investment trust (the “Clover Fork Trust”), which had invested in the Company.As contemplated by the Definitive Financing Commitment Term Sheet entered into on March 19, 2017 between the Company and a group of its stockholders (the “PRH Group”), which set forth the terms on which the PRH Group would provide financing to the Company (the “2017 Definitive Financing”), Jan Koe resigned from the Board on July 11, 2020.Mr. Bailey currently serves as the Executive Director of Business Development and Marketing at Cornerstone of Recovery (“Cornerstone”),...

Continue reading

Michael Mo, CEO of KULR Technology Group, Inc. is Featured in a New Audio Interview with SmallCapVoice.com

AUSTIN, Texas, July 16, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with KULR Technology Group, Inc. (OTC.QB: KULR), (the “Company” or “KULR”), a leading developer of next-generation thermal management technologies, CEO Michael Mo who discusses the recent news and developments for the Company.The full interview can be heard at: https://www.smallcapvoice.com/7-14-2020-smallcapvoice-interview-with-kulr-technology-group-inc/Speaking with SCV’s Stuart Smith, Mo provides his personal insights into the drivers behind the Company’s financial results of operations for the three months ended March 31, 2020, the path to be cash flow break-even by the fourth quarter of 2020, How KULR will achieve its goal of revenue growth of above 200% year-over-year for Q2 2020, and much more.“These...

Continue reading

Colliers International Group Inc. Announces Normal Course Issuer Bid

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) — Colliers International Group Inc. (NASDAQ: CIGI) (TSX: CIGI) (“Colliers”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by Colliers of its intention to make a normal course issuer bid (the “NCIB”) with respect to its outstanding subordinate voting shares (the “Subordinate Voting Shares”).The notice provides that Colliers may, during the twelve month period commencing July 20, 2020 and ending no later than July 19, 2021, purchase through the facilities of the TSX, alternative Canadian Trading Systems or The NASDAQ Stock Market (“Nasdaq”) up to 3,000,000 Subordinate Voting Shares in total, being approximately 10% of the “public float” as of June 30, 2020 of such class of shares. Purchases of Subordinate Voting Shares through Nasdaq will be made in...

Continue reading

FTI Consulting and Compass Lexecon Lead Chambers Litigation Support 2020 Rankings

WASHINGTON, July 16, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that the Company and its Compass Lexecon subsidiary were recognized as leading firms by Chambers Litigation Support 2020, a guide to top professional services providers in key markets worldwide.With 11 firmwide rankings and three individual rankings, FTI Consulting and Compass Lexecon had the most combined recognitions of any firm in Chambers Litigation Support 2020. FTI Consulting and Compass Lexecon were both ranked as leading firms in the Economic Analysts – Global-wide category.FTI Consulting also was recognized in the following categories:Business Intelligence & Investigations – Asia-Pacific RegionE-Discovery – UK-wideE-Discovery – USA – NationwideForensic Accountants – UK-widePR & Communications – USA – NationwideAsset Tracing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.